Medication info
Anflex Extended Release 300 mg (Sarpogrelate Hydrochloride)

Anflex Extended Release 300 mg (Sarpogrelate Hydrochloride)

Prescription medicationTablet경구
Ingredient · strength
Sarpogrelate Hydrochloride›200mg / 1 tablet
Manufacturer / importer
에스케이케미칼(주)
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201500371 · Approved 2015.01.23 · Insurance code 644704300

Summary

Main use
Improvement of ischemic symptoms (ulcers, pain, etc.) in chronic arterial occlusive disease
Who takes it
Adults
Adult dose
Take Sarpogrelate Hydrochloride extended release 300 mg once daily orally after meals. Do not chew or crush the tablet; take it whole.

Ingredients

Manufacturer
에스케이케미칼(주)

Efficacy & effects

Improvement of ischemic symptoms (ulcers, pain, etc.) in chronic arterial occlusive disease

  • Chronic arterial occlusive disease
  • ulcers
  • pain
  • cold sensation
View approved original text

This medication is used for the improvement of ischemic symptoms such as ulcers, pain, and cold sensation caused by chronic arterial occlusive disease. It improves blood circulation in peripheral vascular diseases such as Buerger's disease, obliterative arterial sclerosis, and diabetic peripheral vascular disease, alleviating the symptoms. This medication helps improve the symptoms by facilitating blood flow and aiding in oxygen supply to the tissues. It reduces uncomfortable symptoms such as pain and cold sensation in patients and promotes wound healing. Overall, it is used to improve ischemic conditions and enhance the quality of life.

How to take

Adult dose

Take Sarpogrelate Hydrochloride extended release 300 mg once daily orally after meals. Do not chew or crush the tablet; take it whole.

Precautions

This medication should not be used in patients with bleeding. Individuals at risk of bleeding, such as those with hemophilia or gastrointestinal bleeding, may experience increased bleeding if this medication is taken. It is safer for women who are pregnant or may become pregnant to avoid this medication, as negative effects on the fetus have been reported in animal studies. Women during menstruation or patients with a tendency to bleed should also take this medication with caution due to the possible increased risk of bleeding. Patients taking anticoagulants or antiplatelet agents should be careful as this medication may increase the risk of bleeding when used together. Patients with severe renal impairment should use this medication cautiously as it may affect the excretion of this drug. Regular blood tests during the use of this medication are recommended to check for adverse reactions. Adverse symptoms such as hives, rashes, dyspepsia, headaches, bleeding, blood pressure changes may occur during treatment; if such symptoms arise, consult a doctor immediately. This medication is not recommended for children due to the lack of established safety.

Side effects and when to seek care immediately

Serious side effects

  • Hives
  • gastrointestinal bleeding
  • cerebral hemorrhage
  • subcutaneous bleeding
  • agranulocytosis
  • anemia
  • thrombocytopenia
  • leukopenia
  • acute hepatitis
  • liver dysfunction
Show 8 more
  • jaundice
  • bleeding tendency
  • severe allergic reactions
  • severe skin adverse reactions
  • respiratory issues
  • liver abnormalities (jaundice)
  • severe neurological symptoms
  • severe edema or urinary problems

Mild side effects

  • Nasopharyngitis
  • conjunctivitis
  • upper respiratory infection
  • dyspepsia
  • constipation
  • diarrhea
  • gastritis
  • gastrointestinal dysfunction
  • hypoglycemia
  • decreased appetite
Show 26 more
  • back pain
  • muscle weakness
  • headache
  • paresthesia
  • cough
  • blood pressure fluctuations
  • atrial fibrillation
  • anxiety
  • urinary difficulty
  • chills
  • heat sensation
  • fever
  • wounds
  • diabetic foot ulcers
  • fractures
  • myalgia
  • dizziness
  • carpal tunnel syndrome
  • spinal stenosis
  • gastric perforation
  • intestinal obstruction
  • exacerbation of Crohn's disease
  • hematemesis
  • liver cirrhosis
  • exacerbation of diabetes
  • angina

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to keep it at room temperature between 1°C and 30°C. Proper storage ensures the medication's effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

See Sarpogrelate Hydrochloride ingredient details

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.